Santa Cruz Biotechnology features a diverse variety of SOGA1 monoclonal antibodies for research applications. SOGA1 monoclonal antibodies are suitable for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). SOGA1, or Suppressor of G-protein signaling 1, plays a critical role in regulating cellular signaling pathways, particularly those involving G-protein coupled receptors. By modulating cellular pathways, SOGA1 maintains cellular homeostasis and influences processes such as cell proliferation and differentiation. Understanding SOGA1 function is crucial for elucidating its involvement in various diseases, including cancer and metabolic disorders. SOGA1 monoclonal antibodies enable precise detection and analysis of SOGA1 expression patterns across different cell types and tissues. Researchers can investigate SOGA1's role in normal physiological processes and disease development through multiple experimental approaches. SOGA1 monoclonal antibodies from Santa Cruz Biotechnology contribute to advancing scientific understanding of cellular signaling mechanisms and potential therapeutic targets.